• Big announcement and Hepatic impairment studies (Ep. 22)

  • Mar 25 2024
  • Duración: 18 m
  • Podcast

Big announcement and Hepatic impairment studies (Ep. 22)  Por  arte de portada

Big announcement and Hepatic impairment studies (Ep. 22)

  • Resumen

  • Today’s show is about hepatic impairment clinical studies. I cover the rationale behind evaluating hepatic impairment, common study designs, and key factors in the analysis and interpretation of the study results. I also share a huge announcement about Aplos NCA, a cloud-based solution for calculating NCA PK parameters. Use the link below to learn more about Aplos NCA.

    Links discussed in the show:

    • FDA guidance
    • EMA guideline
    • Aplos Analytics website
    • You can connect with me on LinkedIn and send me a message
    • Send me a message
    • Sign up for my newsletter


    Copyright Teuscher Solutions LLC

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Big announcement and Hepatic impairment studies (Ep. 22)

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.